Juvenile GM1 gangliosidosis: Clinical, pathological, chemical and enzymatic studies
Authors:
- 1 November 1972
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 3 (6) , 411-434
Abstract
Clinical, histological, chemical and enzymatic studies are reported in five patients in two families with juvenile GM1 gangliosidosis (GM1 gangliosidosis, Type 2). The clinical picture includes onset of mental and motor retardation beginning at about one year of age and progressive neurological decline with death usually within the first decade. Bony deformities, although mild, are often present and are diagnostically helpful. Ganglioside GM1 and a galactose‐containing polysaccharide (similar to keratan sulfate) are stored, β‐galactosidase activities are reduced in tissues and cultured skin fibroblasts; both homozygotes and heterozygotes can be detected by this method. The differentiation of juvenile GM1 gangliosidosis from generalized gangliosidosis (GM1 gangliosidosis, Type 1) is discussed.Keywords
This publication has 18 references indexed in Scilit:
- Tay-Sachs Disease: Prenatal DiagnosisScience, 1971
- GM1-gangliosidosis Types 1 and 2: Enzymatic Differences in Cultured FibroblastsNature, 1970
- GM1 Gangliosidosis Type IIEuropean Neurology, 1970
- Hurler's Syndrome: Deficiency of a Specific Beta Galactosidase IsoenzymeScience, 1969
- Generalized gangliosidosisThe Journal of Pediatrics, 1969
- TYPE-II GM1 GANGLIOSIDOSIS ?The Lancet, 1969
- A simple and accurate micromethod for quantitative determination of ganglioside patternsLife Sciences, 1964
- CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*Journal of Neurochemistry, 1963
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957
- THE QUANTITATIVE ESTIMATION OF CEREBROSIDES IN NERVOUS TISSUEJournal of Neurochemistry, 1956